-
1 Comment
CABIO Biotech(Wuhan) Co., Ltd is currently in a long term uptrend where the price is trading 7.6% above its 200 day moving average.
From a valuation standpoint, the stock is 19.2% more expensive than other stocks from the None sector with a price to sales ratio of 14.8.
CABIO Biotech(Wuhan) Co., Ltd's total revenue rose by 8.5% to $87M since the same quarter in the previous year.
Its net income has dropped by 7.6% to $20M since the same quarter in the previous year.
Finally, its free cash flow fell by 21.3% to $42M since the same quarter in the previous year.
Based on the above factors, CABIO Biotech(Wuhan) Co., Ltd gets an overall score of 2/5.
| Exchange | SHG |
|---|---|
| CurrencyCode | CNY |
| Sector | Healthcare |
| Industry | Biotechnology |
| ISIN | CNE100005X31 |
| PE Ratio | 23.42 |
|---|---|
| Target Price | 17 |
| Beta | 0.38 |
| Market Cap | 1B |
| Dividend Yield | None |
Cabio Biotech (Wuhan) Co., Ltd. engages in the research, development, production, and sale of functional ingredients and bio-based products in China and internationally. The company offers polyunsaturated fatty acids, including arachidonic acid (ARA) and docosahexaenoic acid (DHA); terpenoids, such as beta (ß)-carotene and astaxanthin; and carbohydrates, such as N-acetylneuraminic acid and human milk oligosaccharides. Its products are used in human nutrition, including early life nutrition and dietary supplements; animal nutrition, such as economic animal and pet nutrition; personal care and cosmetics; and synthetic biology applications. The company also engages in the production of food additives and other food products; consulting services in bioengineering, environmental protection, healthcare, and food technologies; research, development, and sale of biological feed and feed additives; food wholesale; technology development; and venture capital activities. Cabio Biotech (Wuhan) Co., Ltd. was founded in 1999 and is based in Wuhan, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 688089.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
